Multicenter ENDURANCE Trial of Patients with Advanced Heart Failure Presented at ISHLT Meeting
NICE, FR (April, 17, 2015) – Yesterday, results of the ENDURANCE destination therapy clinical trail were presented at the 35th Annual International Society for Heart and Lung Transplantation Meeting and Scientific Sessions , by Francis D. Pagani, M.D., Ph.D., University of Michigan, a co-principal investigator for ENDURANCE. Results showed no significant difference in overall patient survival, confirming non-inferiority was established for the HeartWare® assist device compared with the control device for destination therapy in patients with end-stage heart failure.